// App-Quantinova.ai

30 : Hypereosinophilia and Stroke as First Presentation of SLE

Researchers

Presenter

  • Aurore Fifi-Mah

Principal Investigators

  • N/A

Medical Centers

  • Univ of Calgary, Calgary, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Eosinophilic granulomatosis with polyangiitis

  • Lupus

  • Stroke

  • Asthma

  • Methicillin-resistant Staphylococcus aureus (MRSA) infection

Biomarkers

  • Myeloperoxidase

  • Pore forming protein

  • Filamin-C

Drug/Treatment

  • Hydroxychloroquine

  • Prednisone

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved